Capital Analysts, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Capital Analysts, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.76 - $1.47 $960 - $1,858	-1,264 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.63 - $2.27 $796 - $2,869	1,264 New	1,264 $3,000
Q3 2019 Nov 12, 2019	SELL	$0.59 - $0.9 $745 - $1,137	-1,264 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$0.53 - $1.11 $669 - $1,403	1,264 New	1,264 $1,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Capital Analysts, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Analysts, LLC with notifications on news.